Lung Cancer Considered

Lung Cancer Considered

Dr. Stephen Liu and Dr. Narjust Florez host Lung Cancer Considered, the podcast of The International Association for the Study of Lung Cancer (IASLC). IASLC is the only global organization dedicated solely to the study of lung cancer and other thoracic malignancies. Founded in 1974, the association's membership includes more than 11,000 lung cancer specialists across all disciplines in over 100 countries, forming a global network working together to conquer lung and thoracic cancers worldwide. The association also publishes the Journal of Thoracic Oncology, the primary educational and informational publication for topics relevant to the prevention, detection, diagnosis and treatment of all thoracic malignancies. Visit www.iaslc.org for more information. Lung Cancer considered is funded in part by Current sponsors: • AbbVie • AstraZeneca • Gilead • J&J • Summit

Denne podkasten er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(393)

Biomarkers in Lung Cancer: Barriers to Implementation

Biomarkers in Lung Cancer: Barriers to Implementation

Today, IASLC released its 2024 Biomarker Survey, following up on its survey conducted in 2019 which found that one-third of oncologists were unaware of evidence-based guidelines for these tests. To di...

16 Feb 202445min

LCC in Cantonese Chinese: Barriers to Biomarker Testing

LCC in Cantonese Chinese: Barriers to Biomarker Testing

Today, IASLC released its 2024 Biomarker Survey, following up on its survey conducted in 2019 that found one-third of oncologists were unaware of evidence-based guidelines for these tests. To reach a ...

16 Feb 202439min

LCC in Mandarin Chinese: Barriers to Biomarker Testing

LCC in Mandarin Chinese: Barriers to Biomarker Testing

Today, IASLC released its 2024 Biomarker Survey, following up on its survey conducted in 2019 which found one-third of oncologists were unaware of evidence-based guidelines for these tests. To reach a...

16 Feb 202428min

LCC in French: Barriers to Biomarker Testing

LCC in French: Barriers to Biomarker Testing

Today, IASLC released its 2024 Biomarker Survey, following up on its survey conducted in 2019 that found one-third of oncologists were unaware of evidence-based guidelines for biomarker tests. To reac...

16 Feb 202439min

LCC in French Canadian: Barriers to Biomarker Testing

LCC in French Canadian: Barriers to Biomarker Testing

Today, IASLC released its 2024 Biomarker Survey, following up on its survey conducted in 2019 that found one-third of oncologists were unaware of evidence-based guidelines for these tests. To reach a ...

16 Feb 202445min

LCC in Portuguese: Barriers to Biomarker Testing

LCC in Portuguese: Barriers to Biomarker Testing

Today, IASLC released its 2024 Biomarker Survey, following up on its survey conducted in 2019 that found one-third of oncologists were unaware of evidence-based guidelines for these tests. To reach a ...

16 Feb 202436min

LCC in Japanese: Barriers to Biomarker Testing

LCC in Japanese: Barriers to Biomarker Testing

Today, IASLC released its 2024 Biomarker Survey, following up on its survey conducted in 2019 that found one-third of oncologists were unaware of evidence-based guidelines for these tests. To promote ...

14 Feb 202433min

LCC in Spanish: Barriers to Biomarker Testing

LCC in Spanish: Barriers to Biomarker Testing

Today, IASLC released its 2024 Biomarker Survey, following up on its survey conducted in 2019 that found one-third of oncologists were unaware of evidence-based guidelines for these tests. To reach a ...

10 Feb 202438min

Populært innen Vitenskap

fastlegen
tingenes-tilstand
jss
forskningno
liberal-halvtime
sinnsyn
rekommandert
vett-og-vitenskap-med-gaute-einevoll
villmarksliv
dekodet-2
rss-nysgjerrige-norge
diagnose
tomprat-med-gunnar-tjomlid
rss-rekommandert
rss-inn-til-kjernen-med-sunniva-rose
rss-skogkurs-podden
fjellsportpodden
rss-overskuddsliv
hva-er-greia-med
nevropodden